TH133899A - Acid sodium salt 5-cyclo-propyl-2 - {[2- (2,6-difluorophenyl) pyrimidin -5-il] amino} benzoic As a DHODH inhibitor - Google Patents
Acid sodium salt 5-cyclo-propyl-2 - {[2- (2,6-difluorophenyl) pyrimidin -5-il] amino} benzoic As a DHODH inhibitorInfo
- Publication number
- TH133899A TH133899A TH1101001984A TH1101001984A TH133899A TH 133899 A TH133899 A TH 133899A TH 1101001984 A TH1101001984 A TH 1101001984A TH 1101001984 A TH1101001984 A TH 1101001984A TH 133899 A TH133899 A TH 133899A
- Authority
- TH
- Thailand
- Prior art keywords
- pyrimidin
- amino
- benzoic
- difluorophenyl
- sodium salt
- Prior art date
Links
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title claims abstract 4
- 159000000000 sodium salts Chemical class 0.000 title claims abstract 4
- -1 2,6-difluorophenyl Chemical group 0.000 title claims abstract 3
- CZPWVGJYEJSRLH-UHFFFAOYSA-N 289-95-2 Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title abstract 2
- 102100002130 DHODH Human genes 0.000 title 1
- 101710035145 DHODH Proteins 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract 4
- 239000012453 solvate Substances 0.000 claims abstract 3
- 239000000126 substance Substances 0.000 claims abstract 3
- SLSURDZCCVUGLR-UHFFFAOYSA-N 5-cyclopropyl-2-[[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino]benzoic acid Chemical compound OC(=O)C1=CC(C2CC2)=CC=C1NC(C=N1)=CN=C1C1=C(F)C=CC=C1F SLSURDZCCVUGLR-UHFFFAOYSA-N 0.000 claims abstract 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 239000005711 Benzoic acid Substances 0.000 abstract 1
- 235000010233 benzoic acid Nutrition 0.000 abstract 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 abstract 1
Abstract
DC60 (14/03/56) การประดิษฐ์นี้ถูกชี้นำกับเกลือโซเดียมของกรด 5- ไซโคลโพรพิล-2-{[2-(2,6-ไดฟลูออ- โรฟีนิล)ไพริมิดิน-5-อิล]อะมิโน}เบนโซอิค (5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5- yl]amino}benzoic acid) และโซลเวทของสารนี้ที่ยอมรับได้ทางเภสัชกรรม การประดิษฐ์นี้ถูกชี้นำกับเกลือโซเดียมของกรด5-ไซโคลโพรพิล-2-{[2-(2,6-ไดฟลูออ- โรฟีนิล)ไพริมิดิน-5-อิล]อะมิโน}เบนโซอิค(5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5- yl]amino)}benzoic acid)และโซลเวทของสารนี้ที่ยอมรับได้ทางเภสัชกรรม สิทธิบัตรยา DC60 (14/03/56) This invention was directed to the sodium salt of 5-cyclopropyl-2 - ((2- (2,6-diplo-rophenyl) pyrimidine). -5-il] amino} benzoic (5-cyclopropyl-2 - {[2- (2,6-difluorophenyl) pyrimidin-5- yl] amino} benzoic acid) and solvate of this substance are pharmacologically acceptable. This invention was directed to the sodium salt of 5-cyclopropyl-2 - ([2- (2,6-dipflu-rophenyl) pyrimidin-5-il] ami. No} benzoic (5-cyclopropyl-2 - {[2- (2,6-difluorophenyl) pyrimidin-5- yl] amino)} benzoic acid) and solvate of this substance, which is acceptable for pharmaceuticals, drug patents.
Claims (1)
Publications (2)
Publication Number | Publication Date |
---|---|
TH133899B TH133899B (en) | 2014-05-26 |
TH133899A true TH133899A (en) | 2014-05-26 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL214518A0 (en) | Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as dhodh inhibitor | |
MY183312A (en) | Pharmaceutical formulation | |
MY170935A (en) | Neprilysin inhibitors | |
MX2013005533A (en) | Substituted amino bisphenyl pentanoic acid derivatives as nep inhibitors. | |
MX343753B (en) | Neprilysin inhibitors. | |
SG191175A1 (en) | Neprilysin inhibitors | |
EA201400553A1 (en) | 2- (1,2,3-triazol-2-yl) benzamide and 3- (1,2,3-triazol-2-yl) picoline amide | |
EA201290191A1 (en) | N1-PYRAZOLOSPIROKETONE INHIBITORS ACETYL-KoA-CARBOXYLASE | |
MY163394A (en) | Substituted aminobutyric derivates as neprilysin inhibitors | |
IL221680A0 (en) | Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms | |
EA201691119A1 (en) | DERIVATIVES OF UREA OR THEIR PHARMACOLOGICALLY ACCEPTABLE SALTS | |
RS53521B1 (en) | Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide | |
PH12014502210A1 (en) | Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one | |
SMT201500068B (en) | New analogues of piperazine as broad-spectrum antivirals for influenza | |
RS53419B (en) | Formulations of deoxycholic acid and salts thereof | |
EA201390771A1 (en) | METHOD OF OBTAINING PHARMACEUTICAL INTERMEDIATE COMPOUNDS OF HIGH PURITY | |
TH133899A (en) | Acid sodium salt 5-cyclo-propyl-2 - {[2- (2,6-difluorophenyl) pyrimidin -5-il] amino} benzoic As a DHODH inhibitor | |
EA201591487A1 (en) | DERIVATIVES OF SUBSTITUTED BISFENILBUTANIC ACID AS NEP INHIBITORS WITH IMPROVED IN VIVO EFFICIENCY | |
TH133899B (en) | Acid sodium salt 5-cyclo-propyl-2 - {[2- (2,6-difluorophenyl) pyrimidin -5-il] amino} benzoic As a DHODH inhibitor | |
EA201290051A1 (en) | CRYSTAL FORM I SALT ROSUVASTATINA ZINC | |
DOP2014000116A (en) | INHIBITORS OF THE PEPTIDE DESFORMILASA | |
TH142278A (en) | New benzoic acid amide compounds | |
EA201390700A1 (en) | CRYSTALLINE PHARMACEUTICAL ACTIVE INGREDIENTS | |
TH138979A (en) | New compound useful for the treatment of degenerative and inflammatory diseases | |
TH160830A (en) | Pyrimidylsulfonamide derivatives for use as a moderator of chemokine receptors. |